A new surgical approach for chronic periprosthetic joint infection (PJI) is showing striking results. Researchers at the University of Pittsburgh Medical Center compared rapid exchange arthroplasty — a novel technique combining elements of single- and two-stage procedures — against historical controls who underwent the standard two-stage exchange. At 24 months, the rapid exchange group fared dramatically better.

The key to the approach lies in aggressive local antibiotic delivery: patients received intra-articular cyclic irrigation with tobramycin daily for 7 days, followed by hourly vancomycin irrigation. This targets antibiotic-tolerant biofilm — a major culprit in persistent joint infections — that conventional systemic antibiotics often can't reach. Notably, the rapid exchange group included patients with more prior surgeries and a higher proportion of multidrug-resistant bacteria, making the results even more impressive.

By the Numbers:

• 10% failure rate with rapid exchange arthroplasty vs. 60% with two-stage exchange
• Patients in the two-stage group were nearly 10x more likely to fail treatment
• Two-stage group also had a higher rate of reoperation for any reason

Why it matters: PJI is one of the most feared complications of joint replacement surgery, and repeat two-stage exchanges carry high failure rates. Rapid exchange arthroplasty could offer a more effective, less burdensome path forward for patients with recalcitrant infections.